Ozempic for Teens: What the Label Says and What Parents Need to Know

Ozempic for teens comes up in clinics more often than it used to. A friend posts about it, a cousin's kid is 'on the shot,' and suddenly the whole family wants to know if it's an option. The starting point is simple. Semaglutide is the active ingredient. Ozempic and Wegovy are brand names with different labels, and the age question depends on which label you're reading and which country you're in.

Why parents are asking now

Many parents show up with a mix of names picked up online: Ozempic, Wegovy, semaglutide, sometimes used as if they meant the same thing. They don't. Semaglutide is the molecule. Ozempic and Wegovy are brands that contain it, sold at different doses and approved for different uses. The label defines who a medicine is officially meant for, so that's the document worth reading first.

What the label actually covers

Ozempic's label is written for adults with type 2 diabetes. Wegovy is approved for chronic weight management, and the US label includes adolescents aged 12 and older with obesity. Approvals get updated, and the situation in Europe and Brazil can differ from the American one. In Brazil, check the current bula on ANVISA's consultation portal before assuming there is an adolescent indication, because the US label doesn't carry over automatically. The bula is the primary source. If you want a plain-language way to read one, the label-reading guide from the OzemBlog team walks families through the sections that matter most.

When a label mentions 'limited pediatric data,' it means fewer studies in young people, fewer participants and shorter follow-up. It doesn't mean the medicine is dangerous for teens. It means we know less about what happens over years, especially around growth and development.

Off-label prescribing: what it means for a teenager

Using a medicine outside its label, called off-label use, does happen in pediatric care. It requires a documented clinical reason. The decision usually belongs to the treating physician, often a pediatric endocrinologist, who should discuss approved alternatives for the teen's age before going further.

Some other diabetes medicines carry pediatric labeling. In the United States, liraglutide and dulaglutide have type 2 diabetes indications for children starting at age 10. Confirm the age range and current status in your country before the appointment, because labels change.

A second opinion is a reasonable request, especially if the reason for choosing this medicine isn't clear. Ask which approved options were considered and why they were set aside, what the treatment goal is and how progress will be measured, and what the plan looks like if the medicine needs to stop.

Side effects worth discussing before starting

Stomach-related effects are the most common concern. Nausea, constipation, diarrhea and vomiting tend to show up during dose increases and often ease with time. Still, report every symptom to the doctor instead of waiting for it to pass on its own.

The label warns that vomiting and diarrhea can lead to dehydration, and dehydration has been linked to kidney problems. If your teen can't keep fluids down, call the doctor the same day. Don't wait to see how it goes.

The label also warns about pancreatitis and gallbladder problems, and about low blood sugar when semaglutide is combined with insulin or a sulfonylurea. In those cases the doctor may need to lower the dose of the other medicines. Never change them on your own. Get urgent care if your teen has any of these:

• Severe belly pain that spreads to the back, with or without vomiting, or pain under the right ribs with yellow skin or eyes.
• Vomiting or diarrhea that won't stop, or signs of dehydration such as dizziness and very little urine.
• Shakiness, sweating or confusion, which can point to low blood sugar.

The label also lists a contraindication for people with a personal or family history of medullary thyroid carcinoma. We covered that topic in depth earlier on this blog, so it's worth reading there before the appointment.

Mental health, eating patterns and growth

The Wegovy label includes guidance to monitor for mood changes, depression and suicidal thoughts in people using it for weight management. Read the current version for the exact wording, and talk about it with your teen before starting. Changes at home are easier to notice when everyone knows what to look for. OzemBlog has a short checklist of warning signs families can watch for between visits, which helps when a teen won't say how they feel.

Restrictive eating and disordered eating are risks worth watching in any weight-related treatment. The American Academy of Pediatrics' 2023 clinical practice guideline on childhood obesity recommends multidisciplinary care, which often means a physician working alongside a dietitian and a psychologist. If your teen starts skipping meals or talking obsessively about numbers, bring that to the team early.

Questions about growth, puberty and bone health are fair ones. Long-term data in minors are limited, so no one can offer full reassurance on these points yet. Regular follow-up is how the team tracks growth and development over time.

What parents can do at home and in the appointment

A simple notebook helps. Record symptoms, weight and eating patterns, but keep it light. The goal is to spot changes, not to turn your teen's body into a daily checkpoint, which can add stress and feed unhealthy habits.

Bring written questions. Ask why this medicine was chosen over others, what the follow-up plan is, when treatment would stop and which tests will be ordered. OzemBlog's family guide has a list of questions organized by topic, so nothing gets forgotten once you're in the room.

Your teen has a voice in this decision. Brazil's Estatuto da Criança e do Adolescente recognizes adolescents as people with rights to respect and dignity. Ask the clinic how it handles private conversations with teens, because confidentiality policies vary between services. Shared decisions usually work better than decisions made over the teen's head.

Don't stop the medicine on your own. If something feels wrong or the family wants to change course, talk to the prescribing doctor first. Stopping without a plan leaves the team unable to decide what comes next, whether that's a dose change, a switch or a pause.

FAQ

Is Ozempic approved for teenagers?

The Ozempic label is written for adults with type 2 diabetes. Any use in adolescents is off-label and depends on the doctor's clinical justification. Check the current label in your country.

Is Wegovy approved for children?

In the United States, the Wegovy label includes chronic weight management in adolescents aged 12 and older with obesity. Status in Europe and Brazil may differ, so confirm it in the current bula or with the prescribing doctor.

Is off-label Ozempic use in adolescents safe?

Safety data in young people are limited. The doctor weighs possible benefits against known risks and available alternatives. Ask about the reasoning, the monitoring plan and the approved options that were considered.

What side effects should parents watch for in a teen?

Stomach symptoms are the most common. Call the doctor for persistent vomiting or diarrhea, severe belly pain that spreads to the back, pain under the right ribs, yellow skin or eyes, or signs of low blood sugar.

Sources

• FDA, Drugs@FDA: Wegovy (semaglutide) prescribing information, NDA 215256
• FDA, Drugs@FDA: Ozempic (semaglutide) prescribing information, NDA 209637
• FDA, Drugs@FDA: Victoza (liraglutide) prescribing information, NDA 022341
• FDA, Drugs@FDA: Trulicity (dulaglutide) prescribing information, BLA 125469
• European Medicines Agency, Ozempic EPAR and product information
• ANVISA, consulta de medicamentos e bulas
• American Diabetes Association, Standards of Care in Diabetes 2024, Section 14: Children and Adolescents
• Hampl SE et al., Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity, Pediatrics (2023)
• Lei nº 8.069/1990, Estatuto da Criança e do Adolescente